SELLAS Life Sciences Group, Inc.

NASDAQ:SLS

Biotechnology

Healthcare
$17.95 +4.02%

+$0.31 today

Market cap
$3.66B
Beta
2.53
P/E (TTM)
-47.3
EPS (TTM)
-$0.17
52W Low $1.39High $9.51

Volume 35.53M

Average 7.79M

Price history

SELLAS Life Sciences Group, Inc. SEC filings

Start with how the market priced the stock, then connect its moves to the disclosures filed with the SEC.

Price history

Dividend-adjusted closing price

Period change

+1028.93%

Period high

$19.15

Period low

$1.39

Latest

$17.95

SEC filings

What has the company disclosed?

Browse annual, quarterly, and current reports and other filings by form type.

SEC Filings

Recent regulatory filings

FormFiling DateAccepted
10-QNov 12, 2026Nov 12, 2026
8-KNov 12, 2026Nov 12, 2026
SC 13GNov 10, 2026Nov 10, 2026
SC 13G/AOct 27, 2026Oct 27, 2026
10-QAug 11, 2026Aug 11, 2026
8-KAug 11, 2026Aug 11, 2026
SC 13GAug 7, 2026Aug 7, 2026
SC 13GJul 31, 2026Jul 31, 2026
8-KJul 27, 2026Jul 27, 2026
8-KJun 25, 2026Jun 25, 2026
8-KJun 18, 2026Jun 18, 2026
4Jun 18, 2026Jun 18, 2026
S-8Jun 16, 2026Jun 16, 2026
8-KJun 2, 2026Jun 2, 2026
10-QMay 12, 2026May 12, 2026

Competitors

Who does SELLAS Life Sciences Group, Inc. compete with?

Open similar companies to compare their filings and price history.

Questions

Filing questions

Common questions about SLS's filings, answered from its disclosures.

What is the latest SLS filing?

The latest filing shown is 10-Q dated Nov 12, 2026.

How many recent filings does SLS have?

Intrinsic Alpha currently shows 20 recent filings for SLS.